Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

162.94 -1.49 (-0.91%)
Streaming Delayed Price Updated: 1:32 PM EDT, Jul 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
Law Offices of Howard G. Smith Encourages Insulet Corporation (PODD) Shareholders to Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Investor Notice: Robbins LLP Informs Investors of the Insulet Corporation Securities Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026
From Insulet Corporation
Via Business Wire
Insulet Corp (NASDAQ:PODD): Strong Growth Stock Consolidating Near Resistance for a Potential Breakout ↗
Via Chartmill
INSULET CORP (NASDAQ:PODD) Fits the Affordable Growth Mold with Strong Momentum and Reasonable Valuation ↗
Via Chartmill
What's going on in today's after hours session: S&P500 movers ↗
Via Chartmill
News headline image
Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including... 
Via StockStory
Topics Artificial Intelligence
News headline image
Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors
From Insulet Corporation
Via Business Wire
News headline image
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
1 Mid-Cap Stock Worth Your Attention and 2 We Question
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
From Insulet Corporation
Via Business Wire
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
Which S&P500 stocks are moving on Friday? ↗
Via Chartmill
News headline image
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out? 
Via The Motley Fool
News headline image
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
From Insulet Corporation
Via Business Wire
News headline image
3 Reasons We’re Fans of Insulet (PODD)
Shareholders of Insulet would probably like to forget the past six months even happened. The stock dropped 54.4% and now trades at $144.10. This might have i... 
Via StockStory
News headline image
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
From Insulet Corporation
Via Business Wire
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States. 
Via The Motley Fool
Topics Regulatory Compliance
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
From Insulet Corporation
Via Business Wire
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
From Insulet Corporation
Via Business Wire
News headline image
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>